|
About half of all men experience hair loss by the age of 50, the most common form being male pattern hair loss, representing close to 95% of all cases of hair loss in men. Hair loss can begin as early as your teen years, slowly progressing over time until you are noticeably going bald. Male pattern hair loss (MPHL) is a progressive condition, beginning with a receding hairline and/or slow balding at the crown. It is believed that male pattern hair loss is genetically inherited, passed down from either side of the family. You could receive a gene from either parent which makes your more susceptible to a hormonal imbalance causing hair loss.
Other evidence also links the hormone dihydrotestosterone, or DHT, as a key factor in hair loss. DHT is believed to play a role in shrinking the hair follicles until it no longer produces visible hair, resulting to discernable hair loss patterns.
Propecia is the first and only oral medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of male pattern hair loss (MPHL) on the vertex (top of the head) and anterior mid-scalp area (middle front of head) in men. However, there is no sufficient evidence demonstrating the effectiveness of Propecia on receding hairlines at the temples.
Propecia has been formulated for the treatment of male pattern hair loss (MPHL) in men only, and should not be used by women or children. Women who are or may potentially be pregnant should not use Propecia or handle crushed or broken Propecia tablets because of the potential teratogenic effects on male fetuses.
Because male pattern hair loss is a progressive condition, the sooner you do something about it, the better are your chances of retaining what hair you have and possibly regrow some of the hair you've lost. |
Get
this FREE Ebook!
